Suriname vs Tunisia: Access to anti-retroviral drugs, male
Suriname
41.0%
in 2024
Tunisia
28.0%
in 2024
Suriname rank
130th
Tunisia rank
133rd
Access to anti-retroviral drugs, male over time
- Suriname
- Tunisia
How they compare
Suriname currently reports 41.0% against 28.0% in Tunisia, a difference of 13.0%.
That makes Suriname's figure about 1.5 times Tunisia's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Tunisia ahead.
Suriname ranks 130th and Tunisia ranks 133rd of 141 countries.
Suriname has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Suriname | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.6% | 3.7% | 1.9% | Suriname |
| 2010s | 25.2% | 10.5% | 14.7% | Suriname |
| 2020s | 37.6% | 22.0% | 15.6% | Suriname |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Suriname or Tunisia?
- Suriname, at 41.0% against 28.0% in Tunisia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Suriname and Tunisia?
- 13.0%, with Suriname ahead.
- How many years of comparable data are there for Suriname and Tunisia?
- 25 years are reported by both, from 2000 to 2024.
- How do Suriname and Tunisia rank globally for access to anti-retroviral drugs, male?
- Suriname ranks 130th and Tunisia ranks 133rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.